Can it separate higher-risk from lower-risk patients?
Discrimination includes sensitivity, specificity, and AUC. AUC measures ranking—not accuracy, calibration, or clinical benefit.
Ask: What errors occur at the threshold we would actually use?
A high AUC and an impressive abstract are not enough. Use five clinical questions to decide whether a prediction model is informative, transportable, and safe enough to influence care.
Start with the claim
The outcome occurred in 3% of patients. A model that predicts “no amputation” for everyone is also 97% accurate.
Ask these in order. A failure early in the chain weakens everything that follows.
Discrimination includes sensitivity, specificity, and AUC. AUC measures ranking—not accuracy, calibration, or clinical benefit.
Ask: What errors occur at the threshold we would actually use?
Calibration asks whether predicted risks match observed risks. If patients assigned 40% risk experience the outcome 20% of the time, the number is not decision-ready.
Ask: Show me the calibration plot, intercept, and slope—not only AUC.
Training performance is not evidence. Internal resampling helps; temporal or external validation tests whether the model survives a new setting, time, or population.
Ask: Was the final model evaluated on data untouched by model development?
Imputation, feature selection, normalization, duplicate patients, or future information can quietly expose the test set to training.
Ask: Were all preprocessing decisions learned inside the training data only?
Transportability and usefulness depend on setting, workflow, threshold, harms, and available alternatives. Better prediction does not automatically produce better care.
Ask: What action changes, for whom, and is there evidence of net benefit?
Answer all five. “Unclear” counts against the paper because incomplete reporting prevents appraisal.